Dr. Christopher P. Ogrady, MD

Dr. Ogrady practices at Andrews Institute Asc - HOPD in Gulf Breeze, Florida.

Dr. Ogrady's NPI, 1629058656, was assigned on January 17, 2006. Dr. Ogrady graduated from Georgetown University School Of Medicine in 1997. Dr. Ogrady holds Florida license ME 87161.

Dr. Ogrady's primary practice is Andrews Institute Asc - HOPD, at 1040 Gulf Breeze Pkwy, Gulf Breeze, FL 32561.

Dr. Ogrady's primary practice is Andrews Institute Asc - HOPD in Gulf Breeze, Florida. Dr. Ogrady is also affiliated with Gulf Breeze Hospital. The medical group on file is North Florida Surgeons. Dmand AI also links Dr. Ogrady to 3 more hospitals, 5 home health agencies, 2 group practices and clinics, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ogrady practices, 13 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Ogrady's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Ogrady is board certified in orthopaedic sports medicine by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Ogrady's licenses on file in 4 states: Florida, Alabama, Louisiana and New York.

Dmand AI lists arthritis, bursitis, joint arthropathy, joint pain, knee arthroscopy, knee injury, knee replacement and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Ogrady treats.

CMS data shows 1,246 Medicare services from Dr. Ogrady across 16 procedure codes in 2024, for 348 Medicare patients. Medicare paid $214,503 for them.

CMS counts 348 Medicare patients who saw Dr. Ogrady in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ogrady's median patient age at 68, with 50% women.

In 2024, Dr. Ogrady wrote 523 Medicare Part D claims for 198 patients. 100% of them were for generic drugs. CMS names the drug for 478 of them, across 8 drugs with 11 or more claims each, at $3,515 in total drug cost. In 2023, CMS named 408 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Ogrady for performance year 2024, reported as part of a group. Dr. Ogrady accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ogrady as offering telehealth. CMS counts 124 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Ogrady, more than 97% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Ogrady to 7 clinical trials. 1 is still active or recruiting. Conditions studied include Rotator Cuff Injuries, Rupture and Arthritis, Rheumatoid. Smith & Nephew, Inc. sponsors the most, 3.

CMS Open Payments shows 594 general payments to Dr. Ogrady from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. Zimmer Biomet Holdings, Inc. paid the most, $105,562.

Dr. Ogrady graduated from Georgetown University School Of Medicine in 1997.

Dr. Ogrady is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.